Etanercept treatment in patients with rheumatoid arthritis on dialysis
Short Communication
First Online:
Received:
Accepted:
- 247 Downloads
- 6 Citations
Keywords
Rheumatoid Arthritis Methotrexate Infliximab Rheumatoid Arthritis Patient Etanercept
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Notes
Conflicts of interest statement
None.
References
- 1.Nakamura M, Sakemi T, Nagasawa K (1999) Severe pancytopenia caused by a single administration of low dose methotrexate in a patient undergoing hemodialysis. J Rheumatol 26:1424–1425PubMedGoogle Scholar
- 2.Sin R, Cuchacovich R, Huang W, Espinoza LR (2002) Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis. J Rheumatol 29:636–637Google Scholar
- 3.Yee AM, Pochapin MB (2001) Treatment of sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27–31PubMedGoogle Scholar
- 4.Ortis-Santamaria V, Valls-Roc M, Sanmari M, Olive A (2003) Anti-TNF treatment in secondary amyloidosis. Rheumatology 42:1425–1426CrossRefGoogle Scholar
- 5.Hammoudeh M (2006) Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis. Rheumatology 45:357–359CrossRefPubMedGoogle Scholar
- 6.Sugioka Y, Inui K, Koike T (2008) Use of etanercept in a patient with rheumatoid arthritis on hemodialysis. Mod Rheumatol 18:293–295CrossRefPubMedGoogle Scholar
- 7.Lee H, Kimko HC, Rogge M, Wang D, Nestorov I, Peck CC (2003) Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis. Clin Pharmacol Ther 73:348–365CrossRefPubMedGoogle Scholar
- 8.Don BR, Spin G, Nestorov I, Hutmacher M, Rose A, Kaysen GA (2005) The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis. J Pharm Pharmacol 57:1407–1413CrossRefPubMedGoogle Scholar
Copyright information
© Springer-Verlag 2010